Literature DB >> 10938388

Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.

S Y Han1, M S Lee, H R Kim, S H Baek, D H Ahn, H S Chae, R H Erickson, M H Sleisenger, Y S Kim.   

Abstract

Phorbol esters such as phorbol 12-myristate 13-acetate (PMA) have been reported to modulate diverse cellular responses through signal transduction pathways including the protein kinase C (PKC) pathway. In the present study, we sought to determine the effect of PMA on mucin gene expression and on the biological properties of a human colon cancer cell line, HM3. The cells were treated for 8 and 24 h with various concentrations of PMA and total RNA was extracted and Northern and slot blot analyses were carried out using MUC2, MUC3 and MUC5AC mucin cDNA probes to assess the steady state levels of mRNA. Spent media were collected and the level of cancer associated carbohydrate antigens (T, Tn, sialyl Tn, sialyl Lex, and sialyl Lea) and matrix-degrading metalloproteinase (MMPs) activity were examined. Trypsinized cells were used for assessing in vitro invasion, motility and adhesion to matrigel. Our results showed that PMA caused upregulation of steady state mRNA levels of MUC2, MUC3 and MUC5AC which was inhibited after treatment with protein synthesis inhibitors. Calphostin C, a highly specific inhibitor of protein kinase C significantly inhibited the PMA induced induction of mRNA levels of MUC2, MUC3, and MUC5AC. The levels of all cancer-associated mucin carbohydrate antigens examined in the media were increased by PMA treatment. PMA also caused an increase in MMPs activity and in in vitro invasion and motility properties, but did not affect adhesion of HM3 cells to matrigel. Thus, PMA caused a significant increase in the expression of all three mucin genes through signaling pathways involving protein kinase C and increased secretion of mucin associated carbohydrate antigens. These changes were associated with increases in MMP activity as well as by increases in the invasive and motility properties of HM3 colon cancer cells. These data suggest that protein kinase C signaling pathways may be involved in mucin gene regulation and in modulating the invasive and metastatic properties of colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938388     DOI: 10.3892/ijo.17.3.487

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Distinctive epidermal growth factor receptor/extracellular regulated kinase-independent and -dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by phorbol 12-myristate 13-acetate.

Authors:  Daphne Yuan-Chen Wu; Reen Wu; Sekhar P Reddy; Yong Chan Lee; Mary Mann-Jong Chang
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells.

Authors:  A Strillacci; C Griffoni; G Lazzarini; M C Valerii; S Di Molfetta; F Rizzello; M Campieri; M P Moyer; V Tomasi; E Spisni
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

3.  Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis.

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Koichi Tsuneyama; Kazuyoshi Katayanagi; Yui Yamamoto; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

4.  Red ginseng extract reduced metastasis of colon cancer cells in vitro and in vivo.

Authors:  Eun Young Seo; Woo Kyoung Kim
Journal:  J Ginseng Res       Date:  2011-09       Impact factor: 6.060

5.  Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-κB-dependent MMP-9 expression.

Authors:  Li Li; Yiwen Wang; Benquan Qi; Dongdong Yuan; Shuying Dong; Daohua Guo; Cuiling Zhang; Meiling Yu
Journal:  Oncol Rep       Date:  2014-08-20       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.